Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | BID | P55957 | 2/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.34 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL401927 | 0.90 | TP53 (0.35) | RARBPPARASOAT1PTGESALOX5 | |
| SCHEMBL14405812 | 0.88 | ICMT (0.40) | RARBLTB4R2NR1H2NR1H3PTGES | |
| SCHEMBL14825124 | 0.86 | RARB (0.45) | RARB | |
| SCHEMBL12069777 | 0.86 | CNR1 (0.33) | RARBPPARASOAT1PTGESALOX5 | |
| SCHEMBL14825128 | 0.86 | RARB (0.44) | RARBLTB4R2NR1H2NR1H3SOAT1 | |
| SCHEMBL14405813 | 0.86 | ICMT (0.38) | RARBNR1H2NR1H3HSD11B1 | |
| SCHEMBL14825119 | 0.84 | RARB (0.42) | RARBLTB4R2NR1H2NR1H3PTGES | |
| SCHEMBL29314516 | 0.84 | RARB (0.39) | RARBLTB4R2NR1H2NR1H3PTGES | |
| SCHEMBL14825131 | 0.83 | RARB (0.39) | RARBLTB4R2NR1H2NR1H3SOAT1 | |
| SCHEMBL18286379 | 0.83 | RARB (0.44) | RARBLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9812644-B2 | Composition containing dopant and co-polymers having non-conjugated spacer units and its use in OLED devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-11-07 | — | — | US | disclosed |
| US-20170040539-A1 | ELECTROACTIVE MATERIALS | LG CHEM, LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
| US-9515267-B2 | Electroactive materials | EI DU PONT DE NEMOURS AND COMPANY (US) | 2016-12-06 | — | — | US | disclosed |
| US-9159927-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-13 | — | — | US | disclosed |
| US-8889269-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| US-20140151660-A1 | POLYMER AND ORGANIC ELECTRONIC DEVICE | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2014-06-05 | — | — | US | disclosed |
| US-8652655-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-02-18 | — | — | US | disclosed |
| US-20130193423-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130087779-A1 | PROCESS AND MATERIALS FOR MAKING CONTAINED LAYERS AND DEVICES MADE WITH SAME | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-11 | — | — | US | disclosed |
| US-20130087779-A1 | PROCESS AND MATERIALS FOR MAKING CONTAINED LAYERS AND DEVICES MADE WITH SAME | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-11 | — | — | US | disclosed |
| US-20130082251-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-04 | — | — | US | disclosed |
| US-20120065432-A1 | ELECTROACTIVE MATERIALS | E.I DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120013245-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-19 | — | — | US | disclosed |
| US-8063399-B2 | Electroactive materials | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-20110095269-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013245-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | RARB 837/4885LTB4R2 1953/4885NR1H2 422/4885 |
| US-20120065432-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | RARB 837/4885LTB4R2 1953/4885NR1H2 422/4885 |
| US-20110095269-A1 | ELECTROACTIVE MATERIALS | NAT1, ADRA1D, ADRA1B | RARB 837/4885LTB4R2 1953/4885NR1H2 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.